Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population

Journal of the American Geriatrics Society

Volumn 49, Issue 8, 2001, Pages 1025-1031

  Peters Jr , Patrick H ^a,b,g   Gravenstein, Stefan ^b   De Bock, Paul Norwood Veerle ^c   Van Couter, Anthony ^d   Gibbens, Michael ^e   Von Planta, Tony Andrea ^f   Ward, Penelope ^c  

^a San Antonio Center for Clinical Research   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c Eeuwfeestkliniek ^*

^d Eeuwfeestkliniek   (Belgium)

^e General Hospital St Jan   (Belgium)

^f Roche Global Development   (Belgium)

^g South Texas Medical Research Associates   (United States)

Author keywords

Influenza; Older; Oseltamivir; Prophylaxis

Indexed keywords

OSELTAMIVIR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; INFECTION PREVENTION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

EID: 0034863463     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2001.49204.x     Document Type: Article

References (33)

1. A study of the impact of influenza on the functional status of frail older people
2. Human influenza
3. Nursing home outbreak of influenza A (H3N2): Evaluation of vaccine efficacy and influenza case definitions
4. Influenza epidemic among a community of elderly people in spite of vaccination
5. Communitywide laboratory-based influenza surveillance focused on older persons
6. Lessons from a nursing home outbreak of influenza A
7. Sequential outbreak of influenza A and B in a nursing home: Efficacy of vaccine and amantadine
8. Outbreaks of influenza A and B in a highly immunized nursing home population
9. Prevention and control of influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP)
10. The efficacy of influenza vaccination in elderly individuals
11. Prevention of Russian influenza by amantadine
12. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
13. Using antiviral agents to control outbreaks of influenza A infection
14. Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes
15. Amantadine-resistant influenza A in a nursing facility
16. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2)
17. Adverse reactions to amantadine prophylaxis of influenza in a retirement home
18. Structure of the catalytic and antigenic sites in influenza virus neuraminidase
19. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity
20. Design of aromatic inhibitors of influenza virus neuraminidase
21. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS4071 protects mice and ferrets against influenza infection
22. Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071
23. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza
24. The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers
25. Brief assessment of the mental state in geriatric domiciliary practice: The usefulness of the mental status questionnaire
26. Zanamivir in the prevention of influenza among healthy adults: A randomized controlled trial
27. Administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes
28. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home
29. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families
30. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine
31. Influenza virus resistance to neuraminidase inhibitors
32. Influenza neuraminidase inhibitors
33. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802